Abstract
Wiskott–Aldrich syndrome (WAS) is an X-chromosome recessive immunodeficiency disease characterized by the triad of thrombocytopenia, eczema, and susceptibility to infection owing to WAS protein gene abnormalities. Kidney transplantation is rarely offered to WAS patients with end-stage renal disease because of concerns that thrombocytopenia and immune disorders may affect the clinical outcome. Here, we report the case of a 20-year-old kidney transplant patient who developed end-stage renal disease owing to immunoglobulin (Ig)A nephropathy caused by WAS. Despite recurrent IgA nephropathy and T-cell-mediated rejection 7 months after transplantation, two rounds of steroid pulse therapy attenuated his renal function and urinary abnormality. His serum creatinine level was maintained at approximately 1.5 mg/dL 1 year after transplantation. No other WAS-related complications were observed throughout the clinical course. Although WAS can cause poor prognosis in kidney transplant patients, careful follow-up may allow kidney transplantation to be performed.
Similar content being viewed by others
References
Malik MA, Masab M. Wiskott-Aldrich syndrome. Treasure Island (FL): StatPearls Publishing LLC; 2021.
Liu C-H, Wu K-H, Lin T-Y, Wei C-C, Lin C-Y, Chen X-X, et al. Wiskott-Aldrich syndrome with IgA nephropathy: a case report and literature review. Int Urol Nephrol. 2013;45:1495–500.
Chovancova Z, Kuman M, Vlkova M, Litzman J. Successful renal transplantation in a patient with a Wiskott-Aldrich syndrome protein (WASP) gene mutation. Transpl Int. 2015;28:1005–9.
Blundell MP, Worth A, Bouma G, Thrasher AJ. The Wiskott-Aldrich syndrome: the actin cytoskeleton and immune cell function. Dis Markers. 2010;29:157–75.
Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111:e622–7.
Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104:4010–9.
Blosser CD, Bloom RD. Recurrent glomerular disease after kidney transplantation. Curr Opin Nephrol Hypertens. 2017;26:501–8.
Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation. 1998;65:1053–60.
Otsuka Y, Takeda A, Horike K, Inaguma D, Goto N, Watarai Y, et al. Early recurrence of active IgA nephropathy after kidney transplantation. Nephrology. 2014;19:45–8.
Park S, Baek CH, Cho H, Yu MY, Kim YC, Go H, et al. Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy. Am J Transplantat. 2019;19:145–55.
Floege J, Grone HJ. Recurrent IgA nephropathy in the renal allograft: not a benign condition. Nephrol Dial Transplant. 2013;28:1070–3.
Meisels IS, Strom TB, Roy-Chaudhury P, Abrams J, Shapiro ME. Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome. Transplantation. 1995;59:1214–5.
Fischer A, Binet I, Oertli D, Bock A, Thiel G. Fatal outcome of renal transplantation in a patient with the Wiskott-Aldrich syndrome. Nephrol Dial Transplant. 1996;11:2077–9.
Maillard MH, Cotta-De-Almeida V, Takeshima F, Nguyen DD, Michetti P, Nagler C, et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4+CD25+Foxp3+ regulatory T cells. J Exp Med. 2007;204:381–91.
Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345–52.
Lionaki S, Panagiotellis K, Melexopoulou C, Boletis JN. The clinical course of IgA nephropathy after kidney transplantation and its management. Transplant Rev (Orlando). 2017;31:106–14.
Kakio Y, Uchida HA, Kitagawa M, Arata Y, Kato A, Inoue-Torii A, et al. IgA nephropathy complicated with X-linked thrombocytopenia. Acta Med Okayama. 2018;72:301–7.
Tomiyoshi Y, Sakemi T, Ikeda Y, Ohtsuka Y, Nakamura M, Fujisaki T. Cellular crescents and segmental glomerular necrosis in IgA nephropathy are indicative of the beneficial effects of corticosteroid therapy. Intern Med. 2001;40:862–6.
Webb MC, Andrews PA, Koffman CG, Cameron JS. Renal transplantation in Wiskott-Aldrich syndrome. Transplantation. 1993;56:1585.
Garnier AS, Augusto JF, Pellier I, Subra JF, Sayegh J. Successful long-term outcome of kidney transplantation in a patient with X-linked thrombocytopenia: 9 year follow-up. Transplantation. 2014;98:e57–8.
Kai K, Sumida M, Motoyoshi Y, Ogawa Y, Miki K, Iwadoh K, et al. Successful long-term graft survival of a renal transplantation patient with Wiskott-Aldrich syndrome. Intern Med. 2016;55:1761–3.
Al Midani A, Donohue C, Berry P, Jones G, Fernando B. Use of thromboelastography to guide platelet infusion in a patient with Wiskott-Aldrich syndrome undergoing renal transplant. Exp Clin Transplant. 2020;18:636–7.
Acknowledgements
The pathological findings of this case were diagnosed by Dr. Takashi Taguchi and Dr. Satoshi Hisano. Unfortunately, both have since passed away.
Funding
The authors received no specific funding for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
The present report and all procedures described in it have been carried out in accordance with the 1964 Declaration of Helsinki and its later amendments.
Informed consent
The patient provided a signed informed consent form for publication of the case report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yamaguchi, K., Kitamura, M., Kawaguchi, Y. et al. A case of early recurrent immunoglobulin A nephropathy and T-cell-mediated rejection in a transplant patient with Wiskott–Aldrich syndrome. CEN Case Rep 11, 60–66 (2022). https://doi.org/10.1007/s13730-021-00631-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-021-00631-9